91
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Novel Nomogram Integrated with Systemic Inflammation Markers and Traditional Prognostic Factors for Adverse Events’ Prediction in Patients with Chronic Heart Failure in the Southwest of China

ORCID Icon, , , , &
Pages 6785-6800 | Received 24 Mar 2022, Accepted 18 Oct 2022, Published online: 20 Dec 2022

References

  • Ponikowski P, Voors A, Anker S, et al. 2016 Esc guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (Esc). Developed with the Special Contribution of the Heart Failure Association (Hfa) of the Esc. Eur J Heart Fail. 2016;18(8):891–975. doi:10.1002/ejhf.592
  • Ponikowski P, Anker S, AlHabib K, et al. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1(1):4–25. doi:10.1002/ehf2.12005
  • Voors A, Ouwerkerk W, Zannad F, et al. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. Eur J Heart Fail. 2017;19(5):627–634. doi:10.1002/ejhf.785
  • Simpson J, Jhund P, Lund L, et al. Prognostic models derived in paradigm-hf and validated in atmosphere and the Swedish heart failure registry to predict mortality and morbidity in chronic heart failure. JAMA Cardiol. 2020;5(4):432–441. doi:10.1001/jamacardio.2019.5850
  • Suter L, Li S, Grady J, et al. National patterns of risk-standardized mortality and readmission after hospitalization for acute myocardial infarction, heart failure, and pneumonia: update on publicly reported outcomes measures based on the 2013 release. J Gen Intern Med. 2014;29(10):1333–1340. doi:10.1007/s11606-014-2862-5
  • Pugliese N, De Biase N, Gargani L, et al. Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing. Eur J Prev Cardiol. 2021;28(15):1650–1661. doi:10.1093/eurjpc/zwaa129
  • Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20(1):248–254. doi:10.1016/0735-1097(92)90167-l
  • Kan H, Finkel M. Interactions between cytokines and neurohormonal systems in the failing heart. Heart Fail Rev. 2001;6(2):119–127.
  • Adamo L, Rocha-Resende C, Prabhu S, Mann D. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17(5):269–285. doi:10.1038/s41569-019-0315-x
  • Dick S, Epelman S. Chronic heart failure and inflammation: what do we really know? Circ Res. 2016;119(1):159–176. doi:10.1161/circresaha.116.308030
  • Reina-Couto M, Pereira-Terra P, Quelhas-Santos J, Silva-Pereira C, Albino-Teixeira A, Sousa T. Inflammation in human heart failure: major mediators and therapeutic targets. Front Physiol. 2021;12:746494. doi:10.3389/fphys.2021.746494
  • Mann D. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res. 2015;116(7):1254–1268. doi:10.1161/circresaha.116.302317
  • Meng Z, Yang J, Wu J, Zheng X, Zhao Y, He Y. Association between the platelet-lymphocyte ratio and short-term mortality in patients with non-st-segment elevation myocardial infarction. Clin Cardiol. 2021;44(7):994–1001. doi:10.1002/clc.23648
  • Benites-Zapata V, Hernandez A, Nagarajan V, Cauthen C, Starling R, Tang W. Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. Am J Cardiol. 2015;115(1):57–61. doi:10.1016/j.amjcard.2014.10.008
  • Jin Z, Wu Q, Chen S, et al. The associations of two novel inflammation indexes, sii and siri with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals. J Inflamm Res. 2021;14:131–140. doi:10.2147/jir.S283835
  • Gao S, Yin G, Xia Q, et al. Development and validation of a nomogram to predict the 180-day readmission risk for chronic heart failure: a multicenter prospective study. Front Cardiovasc Med. 2021;8:731730. doi:10.3389/fcvm.2021.731730
  • Tang Y, Dai F, Razali N, Tagore S, Chern B, Tan K. Sleep quality and bmi in pregnancy- a prospective cohort study. BMC Pregnancy Childbirth. 2022;22(1):72. doi:10.1186/s12884-022-04414-7
  • Stotz M, Pichler M, Absenger G, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer. 2014;110(2):435–440. doi:10.1038/bjc.2013.785
  • Yang Y, Wu C, Hsu P, et al. Systemic Immune-Inflammation Index (Sii) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
  • Hua X, Long Z, Huang X, et al. The preoperative systemic inflammation response index (Siri) independently predicts survival in postmenopausal women with breast cancer. Curr Probl Cancer. 2020;44(4):100560. doi:10.1016/j.currproblcancer.2020.100560
  • Yang A, Liu J, Tao W, Li H. The diagnostic and predictive role of Nlr, D-Nlr and Plr in Covid-19 patients. Int Immunopharmacol. 2020;84:106504. doi:10.1016/j.intimp.2020.106504
  • Paulus W, Tschöpe C, Novel A. Paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263–271. doi:10.1016/j.jacc.2013.02.092
  • Glezeva N, Baugh J. Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target. Heart Fail Rev. 2014;19(5):681–694. doi:10.1007/s10741-013-9405-8
  • O’Connor C, Starling R, Hernandez A, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011;365(1):32–43. doi:10.1056/NEJMoa1100171
  • Chen C, Yang H, Cai D, Xiang L, Fang W, Wang R. Preoperative peripheral blood Neutrophil-to-Lymphocyte Ratios (Nlr) and Platelet-to-Lymphocyte Ratio (Plr) related nomograms predict the survival of patients with limited-stage small-cell lung cancer. Translat Lung Cancer Res. 2021;10(2):866–877. doi:10.21037/tlcr-20-997
  • Kurtul A, Duran M. The correlation between lymphocyte/monocyte ratio and coronary collateral circulation in stable coronary artery disease patients. Biomark Med. 2017;11(1):43–52. doi:10.2217/bmm-2016-0179
  • Graziano V, Grassadonia A, Iezzi L, et al. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Breast. 2019;44:33–38. doi:10.1016/j.breast.2018.12.014
  • Ye G, Chen Q, Chen X, et al. The prognostic role of platelet-to-lymphocyte ratio in patients with acute heart failure: a cohort study. Sci Rep. 2019;9(1):10639. doi:10.1038/s41598-019-47143-2
  • Silva N, Bettencourt P, Guimarães J. The lymphocyte-to-monocyte ratio: an added value for death prediction in heart failure. Nutr Metabol Cardiovasc Dis. 2015;25(11):1033–1040. doi:10.1016/j.numecd.2015.07.004
  • Liu Z, Xv Y, Liu X, Zhou X. Associations of systemic inflammatory markers with the risks of chronic heart failure: a case-control study. Clinics. 2022;77:100056. doi:10.1016/j.clinsp.2022.100056
  • Sciomer S, Moscucci F, Salvioni E, et al. Role of gender, age and bmi in prognosis of heart failure. Eur J Prev Cardiol. 2020;27:46–51. doi:10.1177/2047487320961980
  • Chicco D, Jurman G. Machine learning can predict survival of patients with heart failure from serum creatinine and ejection fraction alone. BMC Med Inform Decis Mak. 2020;20(1):16. doi:10.1186/s12911-020-1023-5
  • Benjamin E, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528. doi:10.1161/cir.0000000000000659
  • Lavie C, Milani R, Ventura H. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925–1932. doi:10.1016/j.jacc.2008.12.068
  • Horwich T, Fonarow G, Hamilton M, MacLellan W, Woo M, Tillisch J. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38(3):789–795. doi:10.1016/s0735-1097(01)01448-6
  • Kannan A, Janardhanan R. Hypertension as a risk factor for heart failure. Curr Hypertens Rep. 2014;16(7):447. doi:10.1007/s11906-014-0447-7
  • Duarte R, Gonzalez M, Oliveira J, Goulart M, Castro I. Is there an association between the nutritional and functional parameters and congestive heart failure severity? Clin Nutr. 2021;40(5):3354–3359. doi:10.1016/j.clnu.2020.11.008
  • O’Connor C, Whellan D, Wojdyla D, et al. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the hf-action predictive risk score model. Circ Heart Fail. 2012;5(1):63–71. doi:10.1161/circheartfailure.111.963462
  • Zhuang B, Shen T, Li D, et al. A model for the prediction of mortality and hospitalization in Chinese heart failure patients. Front Cardiovasc Med. 2021;8:761605. doi:10.3389/fcvm.2021.761605